Skip to main content
Clinical Trials/TCTR20230518002
TCTR20230518002
Recruiting
Phase 4

The study to evaluate the efficacy and safety of using Platelet-rich plasma in treatment of Tear Trough Deformity

ASTRACO MEDICAL NETWORKS LTD.0 sites30 target enrollmentMay 18, 2023

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Healthy
Sponsor
ASTRACO MEDICAL NETWORKS LTD.
Enrollment
30
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 18, 2023
End Date
March 4, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
ASTRACO MEDICAL NETWORKS LTD.

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged 30\-60 years
  • 2\. Tear Trough Class I\-II by Hirmard's Classification

Exclusion Criteria

  • 1\. Pregnancy or Lactation subjects
  • 2\. Subjects with coagulopathy or platelet dysfunction or anemia or cancer or immunocompromised host
  • 3\. Current smoking or heavy alcohol drinking subjects
  • 4\. Subjects with dermatitis, skin infection at eye
  • 5\. Subjects with history of anesthesia allergy
  • 6\. Subjects with history of taking contraceptive pills or NSAIDs
  • 7\. Subjects who treated with energy\-based deviced, laser or botox within 6 month before joining the research
  • 8\. Subjects who had history of keloid
  • 9\. Subjects who had history of phychiatric disease

Outcomes

Primary Outcomes

Not specified

Similar Trials